Shenzhen Haiwang Bioengineering Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
I. Introduction to Abnormal Stock Trading Fluctuations
The stock price of Shenzhen Haiwang Bioengineering Co., Ltd. experienced a cumulative decline of over 12% in closing prices over three consecutive trading days from May 22 to May 26, 2026. According to the relevant provisions of the Shenzhen Stock Exchange Trading Rules, this constitutes an abnormal fluctuation in stock trading.